Is Toxoplasmosis Prophylaxis Necessary in Cardiac Transplantation? Long-term Follow-up at Two Transplant Centers

Journal of Heart and Lung Transplantation

Volumn 25, Issue 11, 2006, Pages 1380-1382

  Baran, David A ^a   Alwarshetty, Mamata M ^a   Alvi, Saad ^a   Arroyo, Luis H ^a   Lubitz, Steven ^b   Pinney, Sean ^b   Gass, Alan L ^b   Zucker, Mark J ^a  

^a NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID; TSUKUBAENOLIDE;

ADULT; ARTICLE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART GRAFT; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPPORTUNISTIC INFECTION; ORGAN DONOR; PNEUMOCYSTIS PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; TOXOPLASMOSIS;

ADULT; ANTI-INFECTIVE AGENTS; ANTIPROTOZOAL AGENTS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; PNEUMONIA, PNEUMOCYSTIS; PYRIMETHAMINE; RETROSPECTIVE STUDIES; SULFADIAZINE; TOXOPLASMOSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 33750612045     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.08.001     Document Type: Article

References (14)

1. Kocher A.A., Bonaros N., Dunkler D., et al. Long-term results of CMV hyperimmune globulin prophylaxis in 377 heart transplant recipients. J Heart Lung Transplant 22 (2003) 250
2. Holliman R.E., Johnson J.D., Adams S., and Pepper J.R. Toxoplasmosis and heart transplantation. J Heart Lung Transplant 10 (1991) 608
3. McCabe R., and Chirurgi V. Issues in toxoplasmosis. Infect Dis Clin N Am 7 (1993) 587
4. Orr K.E., Gould F.K., Short G., et al. Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years. J Infect 29 (1994) 249
5. Snyder M.B., Markowitz N., Saravolatz L.D., et al. Infection surveillance in cardiac transplantation. Am J Infect Control 16 (1988) 54
6. Wreghitt T.G., Gray J.J., Pavel P., et al. Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients. Transplant Int 5 (1992) 197
7. Wreghitt T.G., Hakim M., Gray J.J., et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol 42 (1989) 194
8. Wreghitt T.G., McNeil K., Roth C., Wallwork J., McKee T., and Parameshwar J. Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients. J Infect 31 (1995) 253
9. Hermanns B., Brunn A., Schwarz E.R., et al. Fulminant toxoplasmosis in a heart transplant recipient. Pathol Res Pract 197 (2001) 211
10. Baden L.R., Katz J.T., Franck L., et al. Successful toxoplasmosis prophylaxis after orthotopic cardiac transplantation with trimethoprim-sulfamethoxazole. Transplantation 75 (2003) 339
11. Keogh A., Macdonald P., Richens D., Harvison A., and Spratt P. Mini-dose trimethoprim with sulphamethoxazole prevents pneumocystis and toxoplasmosis infections after heart transplantation. Transplant Proc 24 (1992) 2263
12. Munoz P., Arencibia J., Rodriguez C., et al. Trimethoprim-sulfamethoxazole as toxoplasmosis prophylaxis for heart transplant recipients. Clin Infect Dis 36 (2003) 932
13. Baran D.A., Segura L., Kushwaha S., et al. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results. J Heart Lung Transplant 20 (2001) 59
14. Zucker M.J., Baran D.A., Arroyo L.H., et al. De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. Transplant Proc 37 (2005) 2231